608 related articles for article (PubMed ID: 16249934)
61. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Shawar RM; MacLeod DL; Garber RL; Burns JL; Stapp JR; Clausen CR; Tanaka SK
Antimicrob Agents Chemother; 1999 Dec; 43(12):2877-80. PubMed ID: 10582875
[TBL] [Abstract][Full Text] [Related]
62. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
[TBL] [Abstract][Full Text] [Related]
63. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA
Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
[TBL] [Abstract][Full Text] [Related]
64. Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Balke B; Hogardt M; Schmoldt S; Hoy L; Weissbrodt H; Häussler S
Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):25-30. PubMed ID: 16402226
[TBL] [Abstract][Full Text] [Related]
65. Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Andrés MT; Viejo-Diaz M; Pérez F; Fierro JF
Antimicrob Agents Chemother; 2005 Apr; 49(4):1613-6. PubMed ID: 15793153
[TBL] [Abstract][Full Text] [Related]
66. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment.
MacLeod DL; Nelson LE; Shawar RM; Lin BB; Lockwood LG; Dirk JE; Miller GH; Burns JL; Garber RL
J Infect Dis; 2000 Mar; 181(3):1180-4. PubMed ID: 10720551
[TBL] [Abstract][Full Text] [Related]
67. Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
O'May CY; Reid DW; Kirov SM
FEMS Immunol Med Microbiol; 2006 Dec; 48(3):373-80. PubMed ID: 17052266
[TBL] [Abstract][Full Text] [Related]
68. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.
Dales L; Ferris W; Vandemheen K; Aaron SD
Eur J Clin Microbiol Infect Dis; 2009 Oct; 28(10):1275-9. PubMed ID: 19575248
[TBL] [Abstract][Full Text] [Related]
69. Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis.
Aronoff SC; Klinger JD
J Antimicrob Chemother; 1985 May; 15(5):545-9. PubMed ID: 3924879
[TBL] [Abstract][Full Text] [Related]
70. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L
Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
[TBL] [Abstract][Full Text] [Related]
71. Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms.
Haagensen J; Verotta D; Huang L; Engel J; Spormann AM; Yang K
J Antimicrob Chemother; 2017 Dec; 72(12):3357-3365. PubMed ID: 28961810
[TBL] [Abstract][Full Text] [Related]
72. Genomic and phenotypic comparison of environmental and patient-derived isolates of
Ramsay KA; Wardell SJT; Patrick WM; Brockway B; Reid DW; Winstanley C; Bell SC; Lamont IL
J Med Microbiol; 2019 Nov; 68(11):1591-1595. PubMed ID: 31553303
[TBL] [Abstract][Full Text] [Related]
73. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
74. Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis.
Kuti JL; Pettit RS; Neu N; Cies JJ; Lapin C; Muhlebach MS; Novak KJ; Nguyen ST; Saiman L; Nicolau DP
Diagn Microbiol Infect Dis; 2015 Sep; 83(1):53-5. PubMed ID: 26003469
[TBL] [Abstract][Full Text] [Related]
75. Breakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients: use of high-range Etest strips.
Morosini MI; García-Castillo M; Loza E; Pérez-Vázquez M; Baquero F; Cantón R
J Clin Microbiol; 2005 Sep; 43(9):4480-5. PubMed ID: 16145095
[TBL] [Abstract][Full Text] [Related]
76. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells.
Anderson GG; Moreau-Marquis S; Stanton BA; O'Toole GA
Infect Immun; 2008 Apr; 76(4):1423-33. PubMed ID: 18212077
[TBL] [Abstract][Full Text] [Related]
77.
Thöming JG; Häussler S
Front Cell Infect Microbiol; 2022; 12():851784. PubMed ID: 35295755
[TBL] [Abstract][Full Text] [Related]
78. Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa.
Murphy RA; Coates M; Thrane S; Sabnis A; Harrison J; Schelenz S; Edwards AM; Vorup-Jensen T; Davies JC
Microbiol Spectr; 2022 Aug; 10(4):e0081322. PubMed ID: 35727066
[TBL] [Abstract][Full Text] [Related]
79. Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Elliott D; Burns JL; Hoffman LR
Antimicrob Agents Chemother; 2010 Jul; 54(7):3024-6. PubMed ID: 20404125
[TBL] [Abstract][Full Text] [Related]
80. In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions.
Pompilio A; Crocetta V; Pomponio S; Fiscarelli E; Di Bonaventura G
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):318-25. PubMed ID: 26004353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
